CTRI/2023/05/053319已完成2 期
AN OPEN LABELLED DOUBLE ARM NON-RANDOMISED PHASE II CLINICAL TRIAL, TO COMPARE THE EFFICACY OF VARMA MASSAGE WITH TIRI RAATCHATHA CHOORANAM (INTERNAL) AND MUKUTTU ENNAI (EXTERNAL) IN THE MANAGEMENT OF PIDARI VATHAM
Dr S THAMIZH PRIYAN1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年10月6日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Decrease the intensity of pain
研究概览
简要总结
It is an open labelled Double arm Non-Randomised phase-II Clinical trial to compare the Efficacy of VARMA MASSAGE with TIRI RAATCHATHA CHOORANAM (Internal medicine) MUKUTTU ENNAI (External medicine) in the treatment of PIDARIVATHAM TIRI RATCHATHA CHOORANAM Dosage 1GM thrice daily MUKUTTU ENNAI applied over the affected areas of the body.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Pain in the nape of the neck With or without numbness and pain in the upperlimbs Neck stiffness Giddiness Patient who are willing for admission and stay in IPD or willing to attend OPD.
- •Patient willing to sign Informed consent document.
排除标准
- •History of Trauma/Neck surgery Neoplasm tuberculosis in spine severe osteoporosis of cervical spine congenital anomalies of spine Ankylosing spondylosis Pregnant women and lactating mothers Patient with any other serious systemic illness Syringomyelia.
结局指标
主要结局
Decrease the intensity of pain
时间窗: clinical assessment after 2 weeks
次要结局
- To compare between Group I and II(Outcome will be assed at 6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
2 期
Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLCNon-Small-Cell Lung CancerNCT02672358Novartis Pharmaceuticals
进行中（未招募）
2 期
Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell CarcinomaOvarian Squamous Cell CarcinomaNCT05737199Niigata University Medical & Dental Hospital21
已完成
2 期
PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's LymphomaHodgkin Lymphoma, AdultNCT03155425Jiangsu HengRui Medicine Co., Ltd.75
已完成
2 期
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)Early Breast CancerNCT04436744Hoffmann-La Roche221
Unknown
2 期
SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell LymphomaExtranodal NK/T-cell Lymphoma, Nasal TypeNCT03363555Jiangsu HengRui Medicine Co., Ltd.97